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THE SYNTHESIS PROJECT (Synthesis) is an initiative of the Robert Wood Johnson Foundation to 
produce relevant, concise, and thought-provoking briefs and reports on today’s important health 
policy issues. By synthesizing what is known, while weighing the strength of findings and exposing 
gaps in knowledge, Synthesis products give decision-makers reliable information and new insights to 
inform complex policy decisions. For more information about the Synthesis Project, visit the Synthesis 
Project’s Web site at www.policysynthesis.org. For additional copies of Synthesis products, please go 
to the Project’s Web site or send an e-mail request to pubsrequest@rwjf.org.
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In the wake of the passage of national health reform, the nation is focusing its efforts on how to 
improve quality and efficiency within the health care system. However, expenditures and gaps 
in care delivery are not evenly distributed throughout the population; only 5 percent of the 
population account for half of all health care spending (138) and there is considerable variation 
in quality of care across different conditions and settings (106). Therefore, achieving the goals of 
improved quality and efficiency will require focusing specifically on subgroups most at risk for 
high costs and poor quality of care (113). 
This synthesis presents evidence that persons with comorbid mental and medical conditions 
represent just such a population. Based on epidemiological data from the 2001–2003 National 
Comorbidity Survey Replication, 34 million American adults, or 17 percent of the adult 
population, had comorbid mental and medical conditions within a 12-month period (3, 146). 
The high prevalence of this comorbidity, the complex causal connections linking medical and 
mental health conditions, and system fragmentation lead to problems in quality and costs related 
to comorbidity that are commonly even more complicated and burdensome than the problems 
related to the individual conditions themselves. While evidence-based treatments exist for 
improving care for this population, they typically are not used in routine settings. Under health 
reform, millions of uninsured persons with mental disorders will move into the formal health 
system, in particular the Medicaid program, making efforts to improve quality and efficiency of 
care for this population an even higher priority. 
This synthesis provides an overview of medical and mental comorbidity, with an eye towards  
current federal health reform efforts. It addresses the following questions: 
1. What is the rate of comorbidity between medical and mental conditions and why is it so 
common?
2. What are the associated mortality, quality of care, and cost burdens of comorbidity? 
3. What are the current evidence-based approaches for addressing comorbidity? 
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A literature review and analysis was conducted using standardized approaches for systematic 
reviews of the peer-reviewed literature (69). Quality of evidence was assessed based on internal 
validity (e.g., study design) as well as external validity (e.g., the degree to which the findings can 
be broadly applied). Review articles and meta-analyses received particular attention. We assumed 
that epidemiological associations and mechanisms linking mental and medical disorders would 
be relatively stable over time, and therefore included older studies in these sections; cost and 
service use data were considered to be more time-sensitive, and therefore these sections focused 
on more recent data.
Given the limitations of peer-reviewed data for policy syntheses (97) (e.g., lack of timeliness, bias 
towards positive findings), grey literature including commissioned reports, white papers and legis-
lation also were reviewed. Data were supplemented with discussions with key administrators and 
policy-makers.
For the purposes of this report, comorbidity 
is defined broadly as the co-occurrence of 
mental and physical disorders in the same 
person, regardless of the chronological order 
in which they occurred or the causal pathway 
linking them (52, 147, 148). Mental disorders 
include a spectrum of conditions, such as 
depression, anxiety disorders, schizophrenia and bipolar disorder. This review focuses on adults; 
there are differences in treatments, providers and systems where children with comorbid mental 
and medical conditions receive their care.
Mental disorders cannot be diagnosed with biological tests, unlike many medical conditions, and 
thus case definition relies on diagnostic criteria. In the research literature, mental disorders are 
often measured through self-report, health utilization data, symptom- or criteria-based scales, or 
clinical interviews (see Text Box below). Self-report and claims-based analyses generally capture 
those individuals who have been treated for a particular disorder, whereas symptom-based stud-
ies identify individuals who meet criteria for a mental disorder regardless of whether they have 
been treated. Given the fact that fewer than one-third of individuals meeting criteria for a mental 
disorder receive treatment (86), this distinction is particularly important for this group of condi-
tions. Additionally, prevalence estimates of mental disorders will differ depending on the time 
frame used (e.g., current, 12-month, or lifetime) because of recall bias and the likelihood that 
longer time frames will yield larger numbers of mental disorders (55).
Methodology
Comorbidity – the co-occurrence of mental 
and physical disorders in the same 
person, regardless of the chronological 
order in which they occurred or the 
causal pathway linking them.
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Measuring mental disorders
Self-report: Individuals are asked to state whether or not they have a diagnosis of a mental illness.
Health Utilization Data: Diagnostic codes submitted by health care providers to insurance 
companies are used to determine if individuals have a mental disorder.
Screening Instruments: Interview questions measure symptom duration and severity. These 
instruments are often used for screening purposes to identify potential cases of mental 
disorders or are included in population-based surveys.
Clinical Interviews: Interviews based on standard diagnostic criteria designed to be administered  
by clinicians or lay interviewers in large epidemiological surveys.
In addition to the issue of case definition for mental disorders, different study designs are used 
to evaluate and examine the epidemiology, health services correlates and treatments for comor-
bid mental disorders, including epidemiological surveys, analysis of claims-based data, clinical 
trials, and systematic reviews and meta-analyses (see Table 1). Each type of study provides useful 
information, but needs to be evaluated in terms of its potential strengths and weaknesses. 
Table 1: Types of studies used to examine treatment for mental disorders
Type of Study Example Description
Measurement 
Strategies Strengths Weaknesses
Epidemiological National 
Comorbidity 
Survey (NCS) 
(87)
Large sample 
surveys used 
to determine 
prevalence 
and correlates 
of mental 
disorders in 
the overall 
population.
• Structured lay 
interviews
• Self-report
• Capture 
people with 
and without a 
diagnosis
• Typically 
use a 
representative 
sample
• Expensive to 
conduct
• Difficult to get 
timely data
• Provide less 
information 
on cost and 
services
Claims-based Faces of 
Medicaid 
(96)
Analysis of 
databases 
that include 
diagnostic 
codes and 
other health 
information.
• Health 
utilization 
data
• Timely data
• Good for 
assessing 
cost
• Only capture 
people 
treated for a 
diagnosis
Clinical Trials IMPACT study 
(144)
Randomized 
controlled trials 
test the efficacy 
of a treatment 
or intervention.
• Symptom-
based 
outcome 
measures
• Clinical 
interviews
• Rigorous 
methods for 
determining 
program 
effectiveness
• Examine 
a specific 
population 
and setting
Systematic Review 
and Meta-analysis
Collaborative 
care for 
depression: 
A cumulative 
meta-analysis 
and review of 
longer-term 
outcomes 
(56)
Literature is 
comprehen-
sively searched 
for primary 
studies that 
fit eligibility 
criteria. Results 
are synthesized 
and, for meta-
analyses, 
quantified.
• Variety of 
methods 
depending 
on articles 
identified 
in literature 
search
• Synthesize 
results of 
multiple 
studies
• Meta-
analyses 
provide 
overall effect 
sizes
• Results may 
be influenced 
by publishing 
bias 
(studies with 
significant 
results are 
more likely to 
be published)
Methodology
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What is the rate of comorbidity between mental and medical conditions 
and why is it so common?
Comorbidity between medical and mental conditions is the rule rather than the 
exception. In the 2001–2003 National Comorbidity Survey Replication (NCS-R), a nationally 
representative epidemiological survey, more than 68 percent of adults with a mental disorder 
(diagnosed with a structured clinical interview) reported having at least one general medical dis-
order, and 29 percent of those with a medical disorder had a comorbid mental health condition 
(Figure 1) (3, 83).
Figure 1: Percentages of people with mental disorders and/or medical conditions, 2001–2003
Source: Adapted from the National Comorbidity Survey Replication, 2001–2003 (3, 83)
Studies examining the association between specific medical and mental disorders in nationally 
representative samples have found high rates of comorbidity. For example, in the 1996 Medical 
Expenditure Panel Survey, the risk of self-reported depression among people reporting diabetes 
was two times the risk for individuals without diabetes (50). In the 2006 Behavioral Risk Factor 
Survey, people reporting a diagnosis of asthma were 2.3 times more likely to screen positive for 
current depression compared with people without asthma (141). Conversely, in the 2001–2002 
National Epidemiologic Survey on Alcohol and Related Conditions, persons reporting cardiovas-
cular disease were at 1.43 times elevated risk of having a lifetime anxiety disorder (63).
People with medical conditions:
58% of adult population
People with mental disorders:
25% of adult population
68% of adults with mental disorders 
have medical conditions
29% of adults with medical conditions
have mental disorders
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The Faces of Medicaid III report, which includes analyses of 2002 national Medicaid claims data, 
highlights these patterns among disabled Medicaid recipients (Figure 2) (93). In 2002, more than 
half of disabled Medicaid enrollees with psychiatric conditions also had claims for diabetes, car-
diovascular disease (CVD) or pulmonary disease, substantially higher than rates of these illnesses 
among persons without psychiatric conditions. The authors conclude that the high prevalence of 
psychiatric diagnoses among people with chronic medical conditions should be an impetus for 
prioritizing the improved integration of behavioral and medical care.
Figure 2: Association of medical and psychiatric diagnoses among Medicaid-only beneficiaries with 
disabilities, 2002.
Source: Adapted from Faces of Medicaid III (93)
The investigators also looked at how conditions grouped into “triads” (i.e., common co- 
occurrences of three diseases together). Psychiatric disorders were among seven of the top  
ten most frequent diagnostic comorbidity triads in the most expensive 5 percent of Medicaid 
beneficiaries with disabilities. The most common triad was comorbid psychiatric conditions, 
cardiovascular disease, and central nervous system disorders, which affected 9.5 percent of all 
beneficiaries and 24 percent of the most expensive group of beneficiaries. 
One of the most important drivers of the high numbers of individuals with comor-
bid mental and medical conditions is the high prevalence of mental disorders and 
chronic conditions in the United States. As previously noted, data from the 2001–2003  
National Comorbidity Survey Replication, an epidemiological survey, found that approximately 
25 percent of American adults meet criteria for at least one diagnosable mental disorder in any 
given year (85), and more than half report one or more chronic general medical conditions (70).  
In publicly insured populations, the proportion of clients receiving treatment for one or more 
chronic conditions is even higher; data from the 2001 Medical Expenditure Panel Survey indicate 
that more than 80 percent of Medicare recipients report being treated for one or more chronic  
illnesses (5); and national claims-based data from 2002 indicated that 79 percent of disabled and 
56 percent of nondisabled adult Medicaid enrollees nationwide had one or more chronic condi-
tions (1, 93). 
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In addition to the high prevalence of these conditions, there is also evidence  
that having each type of disorder is a risk factor for developing the other. For 
example, among respondents to the 1999 National Health Interview Survey, a nationally  
representative epidemiological survey, the likelihood of having major depression diagnosed 
via a screening instrument increases with each additional reported comorbid chronic medical 
disorder. The 12-month prevalence of major depression is about 5 percent in people without 
chronic medical conditions, compared with almost 8 percent in people with one  
condition, 10 percent in people with two conditions, and 12 percent in people with three 
or more medical conditions (49). Two claims-based studies of a privately insured population 
found that people treated for schizophrenia or bipolar disorder were up to three times more 
likely to have claims for three or more chronic conditions compared with people without 
claims for mental disorders (17, 18). 
The pathways leading to comorbidity of mental and medical disorders are com-
plex and bidirectional (80). Medical disorders may lead to mental disorders, mental condi-
tions may place a person at risk for medical disorders, and mental and medical disorders may 
share common risk factors. Epidemiological studies have been important in examining these 
pathways. For instance, medical conditions that are accompanied by a high symptom burden, 
such as migraine headaches or back pain, can lead to depression (116). At the same time, major 
depression is a risk factor for developing medical conditions, such as cardiovascular disease, 
that are characterized by pain or inflammation (118). Figure 3 illustrates some of the pathways 
linking medical conditions and mental disorders.
Figure 3: Model of the interaction between mental disorders and medical illness 
Source: Modified from Katon (80)
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Exposure to early trauma and chronic stress may be a risk factor for both mental 
and medical disorders. Results from the Adverse Childhood Experience study (53), a survey  
of approximately 10,000 adults in a Health Maintenance Organization from 1995 to 1996, 
indicate a strong graded response between the level of exposure to childhood abuse or household 
dysfunction and poor health outcomes. People who experience more adverse exposures during 
childhood are more likely to report depression, suicide attempts and chronic medical conditions 
(8, 53, 72). Chronic stressors, such as lack of money for basic needs, care-giving responsibilities, 
conflict in relationships, or dealing with long-term medical conditions, are particularly strong 
predictors of depression (72).
Traumatic events throughout the lifespan, including intimate partner violence or combat expo-
sure, can lead to post-traumatic stress disorder (PTSD). A systematic literature review estimated 
that combat-related PTSD afflicts between 4 percent and 17 percent of American veterans who 
have recently served in Iraq (125). Combat-related trauma can leave soldiers with serious and last-
ing injuries, which negatively affects mental health and contributes to PTSD (65, 91). In one study 
of 613 injured veterans, severity of PTSD and physical problems one month after injury indepen-
dently predicted the severity of PTSD and depression six months later (65).
One mechanism that may underlie the relationship between stress and health conditions is that 
exposure to stressors is linked to a weakening of the immune system and an increase in the inflam-
matory response, which are risk factors for medical disorders (8, 9, 88). Mental disorders, such as 
depression, are linked to altered immune function including increased production of cytokines, 
small signaling proteins that are part of the body’s inflammatory response (30, 89). The inflam-
matory response is critical for dealing with injury or infection, but becomes problematic when 
sustained over time in response to chronic stress (89). In addition, people who experience chronic 
stressors or negative events in childhood may also be more likely to engage in adverse health 
behaviors that are linked with medical conditions (53).
Socioeconomic factors, such as low income and poor educational attainment, are 
associated with mental disorders and medical conditions. A consistent inverse associa-
tion exists between socioeconomic status (SES) and a variety of health indicators, health behaviors 
and mortality (66, 95, 102). For example, a meta-analysis of the literature showed that people of 
low socioeconomic status are 1.8 times more likely to report being depressed than people who 
have a higher status (102). SES may both contribute to the onset of mental disorders and be a 
consequence of downward “drift” resulting from a mental disorder (48). SES can also influence 
prevalence, morbidity and mortality of medical conditions, such as coronary heart disease and 
diabetes (16, 37). People of low socioeconomic status are more likely to engage in adverse health 
behaviors, such as eating a poor diet, smoking and not exercising, which in turn contribute to the 
development of chronic medical conditions (13, 94).
Low socioeconomic status reduces available resources, such as social support, and increases the 
chances of exposure to adverse environmental conditions (119). Individuals with low social sup-
port consistently report higher levels of depressive symptoms; this relationship can be found 
among the general population and among people with various chronic diseases (124, 143, 148). 
There is also evidence that social support may be important in the course of schizophrenia and 
bipolar disorder; people with low social support report poorer outcomes of these illnesses (15, 77). 
Low levels of social support are also negatively linked to medical conditions. For example, one 
review of the literature found that low social support raises the risk of developing coronary heart 
disease (CHD) or experiencing adverse outcomes associated with CHD by 1.5 to 2 times (101). 
Social support is hypothesized to directly influence mental health or indirectly affect health status 
by buffering the effects of stress (143). 
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Environmental and neighborhood conditions associated with disadvantage, such as low-quality 
schools and housing, limited employment prospects, and problems in access to health care 
services, public transportation or other resources, have a profound impact on individuals’ 
well-being and mental health (28, 29). Neighborhood characteristics may lead to depression, 
for example, by increasing daily stress levels, heightening vulnerability to negative events, and 
disrupting social ties (29). 
A 2001 systematic review concluded that neighborhood characteristics are also associated with 
the development of chronic medical conditions (120). For instance, people in disadvantaged 
communities often have limited access to healthy food options and may not be able to afford 
healthier choices, which contributes to high rates of obesity and diabetes (37). In a random 
sample of adults from a Canadian city, neighborhood deprivation was significantly associated 
with disability from diabetes, even when individual characteristics were taken into account 
(129). 
Four modifiable health risk behaviors—tobacco use, excessive alcohol and illicit 
drug consumption, lack of physical activity, and poor nutrition—are responsible 
for much of the high rates of comorbidity, burden of illness, and early death  
related to chronic diseases (19). Persons with mental disorders are at elevated risk for 
each of these types of behaviors, which raises their risk of developing chronic illnesses and  
having poor medical outcomes once the illnesses emerge. 
Using data from the 1991–1992 National Comorbidity Survey, Lasser and colleagues estimated 
that people with a diagnosis of a mental disorder in the past month smoke approximately 
44 percent of all cigarettes in the United States and are two to three times as likely to smoke 
compared with those without a mental disorder (96, 58). More severe symptoms are associated 
with a greater likelihood of smoking; data from the 2005–2008 National Health and Nutrition 
Examination Survey (NHANES) found that as depression symptoms become more severe, 
likelihood of smoking increased (122).
A number of factors may contribute to co-occurrence of smoking and mental illness. Some 
have argued that smoking relieves psychiatric symptoms among some people with severe  
mental illness; however this “self-medication” hypothesis has not been consistently supported 
in the research literature (25). Other factors that may contribute to smoking rates among 
people with mental disorders include low socioeconomic status, social networks that include 
smokers, or environmental facilitators, such as residential or treatment facilities that allow 
smoking (25, 38, 67, 102, 111). Having a mental disorder may also make it more challenging  
for smokers to quit. 
The factors contributing to high rates of smoking among people with mental disorders can 
also contribute to drug and alcohol use. Using employer-based claims data from 1996 to 2001, 
Carney and colleagues found that compared with people without severe mental illness, people 
treated for schizophrenia and bipolar disorder are 12 and 20 times more likely to be treated for 
alcohol abuse, and 35 and 42 times more likely to be dependent on illegal drugs, respectively 
(17, 18). According to a national epidemiological survey, substance use disorders are comorbid 
in roughly 20 percent of people with depression and 15 percent of people with anxiety (64).  
A review of the literature on substance abuse and PTSD found 21 percent to 43 percent of 
civilians with PTSD and up to 75 percent of veterans with PTSD also had a substance abuse 
disorder (75). Individuals may use alcohol and drugs to ameliorate negative psychiatric  
symptoms, to achieve a desired emotional state or to cope with stressors (26, 131).
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Persons with mental conditions are more likely to have sedentary lifestyles and poor diets. The 
high rates of obesity among individuals with mental disorders may be attributable to poor diet 
and sedentary lifestyle (22, 62, 136). People with severe mental illness, including schizophre-
nia, bipolar disorder, or major depression, report less physical activity compared with those 
without mental disorders, and tend to eat foods that are high in fat and calories while avoiding 
fruits and vegetables (25, 31). 
Many of the most common treatments for diseases may actually worsen the 
comorbid mental or medical problems. Most psychotropic medications, particularly  
antipsychotic medications, can cause weight gain, obesity and type 2 diabetes (109). At the 
same time, many treatments for common medical conditions may have psychological side  
effects that may exacerbate or complicate underlying psychiatric conditions. For example,  
corticosteroids are associated with mania and psychosis (92). According to two systematic 
literature reviews, some medications appear to contribute to mild or atypical depressive symp-
toms, though conflicting results about the association with depression have been found for 
commonly used medications such as anti-hypertensives and lipid-lowering agents (92, 117). 
Many chronic medical conditions require patients to maintain a self-care regi-
men in order to manage symptoms and prevent further disease progression, 
which may be hampered by comorbid mental conditions. Self-care behaviors include 
taking medication as prescribed and adhering to lifestyle modifications, which may include  
exercise, diet and stress relief (103). Depression may decrease the motivation and energy needed 
to perform self-management behaviors and may also adversely impact interpersonal relation-
ships, including collaboration with physicians (80). A meta-analysis indicated that the odds of 
noncompliance with medical treatment regimens are three times greater for depressed patients 
compared with nondepressed patients (34). An analysis of the claims-based 2001 Veterans 
Affairs National Psychosis Registry found that people with severe mental illness often exhibit 
poor adherence to both psychiatric medications and medications for medical conditions (121). 
Inadequate self-care can result in an exacerbation of medical symptoms and a decrease in 
health-related quality of life.
What are the associated mortality, quality of care, and cost burdens of 
comorbidity?
When mental and medical conditions co-occur, the combination is associated 
with elevated symptom burden, functional impairment, decreased length and 
quality of life, and increased costs (32, 49, 80, 139). The impact of having comorbid 
conditions is at least additive and at times may be synergistic, with the cumulative burden 
greater than the sum of the individual conditions.
Mental disorders are associated with a twofold to fourfold elevated risk of 
premature mortality (24, 47, 54). From a population perspective, the bulk of these deaths 
are due to “natural” causes such as cardiovascular disease rather than accidents and suicides 
(24). As lifespan in the general population has improved, persons with mental disorders have 
lagged behind, resulting in a widening disparity between persons with and without these 
disorders (127). In a multistate study of mortality data from 1997 to 2000 submitted by public 
mental health agencies, public mental health clients were found to die 25 years earlier than 
the average life expectancy for the general population (24). Based on a review of the literature, 
Eaton et al. calculated the relative risk of premature mortality in people with mental disorders 
compared with the general population (Figure 4).
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Figure 4. Relative risk of all-cause premature mortality associated with mental disorders compared 
with the general population
Source: Eaton et al., 2008 (47)
Excess mortality in persons with mental disorders likely represents a common final pathway of 
socioeconomic disadvantage, poor quality of care, problems in treatment adherence, and adverse 
health behaviors. However, much of this excess mortality, like the excess mortality in general 
populations, is due to preventable risk factors and treatable conditions. Improved access to pre-
ventive services, diet and exercise programs, and high quality of primary care could play a role in 
narrowing the mortality gap for persons with mental illnesses (114). 
There are problems in quality of care for treatment of comorbid conditions both 
in primary care and specialty mental health settings. People with mental and substance 
use disorders are less likely than individuals in the general population to receive preventive 
services such as immunizations, cancer screenings, and smoking cessation counseling, and receive 
worse quality of care across a range of services (42, 108). In primary care, common mental  
comorbidities, such as depression, often go undetected and undiagnosed (27, 68, 154). Many 
common mental disorders, including depression and anxiety, present with somatic symptoms 
such as headaches, fatigue, pain or gastrointestinal problems that overlap with those of general 
medical disorders, making diagnosis of these conditions challenging (61, 132). Few health care 
sites offer systematic screening for detection of these conditions. Similarly, veterans with PTSD 
experience higher rates of physical symptoms compared with veterans without PTSD, though 
more research on the association between PTSD and specific medical conditions is needed  
(6, 51, 123). Among injured veterans, the emphasis of care may focus on physical rehabilitation 
and emotional distress may be overlooked, especially since PTSD and depression symptoms 
among soldiers often emerge over time (65, 91). 
Once diagnosed, providers face time constraints in managing multiple conditions. Competing 
demands may prevent providers from being able to address psychosocial issues during brief office 
visits, which likely is a factor underlying poor quality of care for those conditions in primary care 
settings (23, 90, 158). Similar problems have been found in specialty mental health settings, such 
as the Veterans Affairs system, where having comorbid medical conditions predicts worse quality 
of care for more serious mental disorders (21). 
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There are analogous problems of underrecognition and undertreatment of 
medical problems for persons with mental conditions. For patients, symptoms of 
mental illness such as lack of motivation, fearfulness and distrust may reduce their ability to 
initiate and follow through with medical treatment. Among providers, primary care physicians 
may feel uncomfortable treating persons with serious mental illness. Psychiatrists and other 
mental health care providers may lack the knowledge or expertise to provide medical care 
for their patients. At a system level, fragmentation and separation between the medical and 
mental health care systems result in individuals with comorbid conditions receiving care from 
multiple uncoordinated locations (45). 
Comorbid mental and medical conditions are associated with substantial  
individual and societal costs (39, 87). Melek and Norris analyzed the expenditures  
for comorbid medical conditions and mental disorders using the 2005 Medstat MarketScan  
national claims database (107). They looked at the medical expenditures, mental health  
expenditures, and total expenditures of individuals with one of ten common chronic condi-
tions with and without comorbid depression or anxiety (Figure 5). They found that the  
presence of comorbid depression or anxiety significantly increased medical and mental  
health care expenditures, with over 80 percent of the increase occurring in medical expendi-
tures. For example, the average total monthly expenditure for a person with a chronic disease 
and depression is $560 dollars more than for a person without depression; the discrepancy 
for people with and without comorbid anxiety is $710. 
Figure 5. Comparison of monthly health care expenditures for chronic conditions and comorbid 
depression or anxiety, 2005
 Source: Melek and Norris (107)
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Other studies have found similar results across a range of medical and mental health comor-
bidities. For patients in a staff model HMO, a claims analysis found that general medical costs 
were 40 percent higher for people treated with bipolar disorder than without it (135). Another 
claims-based study, which surveyed over 4,000 adult health plan members with diabetes, found 
that costs attributable to mental health services accounted for less than 15 percent of the 
increase in total costs for people with comorbid diabetes and depression (134). 
Mental disorders also present a high cost to employers. Because mental disorders affect higher 
order functioning, mental comorbidity may result in disproportionate costs for both absentee-
ism and presenteeism (59, 60). Depressive disorders contribute to significantly more sick days 
annually than any other condition. In an analysis of health claims and disability data from 
employees of a large corporation, persons with comorbid mental and medical conditions cost 
employers approximately twice as much as those with either condition alone (43). 
What are the current evidence-based approaches for addressing 
comorbidity?
A literature dating back more than two decades has provided a clear indica-
tion of what does and does not work in care management on the primary care/
mental health interface. Early studies that sought to improve quality of care of common 
mental disorders in primary care through screening and provider education did not find these 
methods to be effective (57). “Collaborative care” approaches that use a multidisciplinary team 
to screen and track mental conditions in primary care settings have been the most effective in 
treating these conditions (16, 56, 142). These models build on the Chronic Care Model, which 
describes the environmental, structural and community characteristics needed for multidisci-
plinary teams to work with patients in improving illness management (152). Table 2 shows the 
key elements of the Chronic Care Model.
Table 2. Elements of the Chronic Care Model
Elements Description
Self-management support • Patient and provider contributions to treatment plan
• Self-management education, training, support services
• Goal setting
Decision support • Guidelines for specialist referral
• Flowchart of guidelines
Delivery system design • Composition of practice team
• Clear roles and allocated tasks 
• Management of patient contacts—e.g., appointments, follow-up
Clinical information systems • Patient and disease registries
• Electronic records
• Reminder systems and feedback to physicians
Health care organization • Support by organization leaders
• Prioritization of chronic care
• Reimbursement policies
Community resources • Collaboration with community groups – e.g., peer support
Source: Adapted from Bodenheimer et al. (10), Wagner et al., 2001 (151), and Wagner et al., 1996 (152)
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More than 30 randomized controlled trials have found that collaborative care interventions  
improve quality and outcomes of major depression as well as anxiety disorders (16, 56, 157).  
In the IMPACT study, the largest collaborative care program for late-life depression, the  
patient, care manager, and primary care physician work together to develop a treatment plan that 
includes antidepressant medication or brief psychotherapy (144). Treatment plans are adjusted 
as needed in weekly meetings with the psychiatrist. This study is now in a dissemination phase, 
helping health plans and state authorities to adopt this model to populations of all ages and to 
presenting problems common to primary care (e.g., depression, anxiety/PTSD, bipolar disorder, 
substance use). Care managers follow up with patients and monitor depressive symptoms using 
the Patient Health Questionnaire-9 (PHQ-9), a brief screening and symptom severity measure. 
Similarly, positive results have been found using these collaborative approaches for improving 
the delivery of primary medical care in specialty settings (40, 44, 128, 153, 156). 
Two key “active ingredients” of these models, identified through a literature review and meta-
analysis, are the use of care managers and the use of “stepped care” approaches to illness man-
agement (11). Care managers provide patient education, aide patients with treatment decision-
making, monitor symptoms, provide follow-up care, and communicate with the team (11, 14, 20, 
33, 56, 142, 144). Stepped care involves tracking and monitoring medical and mental outcomes, 
and adjusting services or moving to a higher level of intensity as needed (104). 
Collaborative care approaches have been found to be highly cost-effective from 
a societal perspective (82, 130). Cost-effectiveness indicates a good value for society, but 
does not necessarily mean that cost-effective programs will save money or result in a “cost-offset” 
(150). However, more recent clinical trials have suggested that cost savings may be achievable 
over the long term, particularly among the costliest and most complex patients, such as those 
with comorbid diabetes and depression (81, 145). 
There are challenges, however, in moving from cost-effectiveness findings to implementation and 
policy, given externalities in the financing of health care in the United States. For instance, if a 
program reduces emergency room visits or hospitalizations, the site funding such a program is 
not typically able to share in these savings (105). Cost-effectiveness analyses need to be supple-
mented with budget impact analyses that seek to understand these costs from the perspective of 
the organizations who implement these programs (99, 105, 112).
There is increasing interest in developing models that use a single care manager to treat a range 
of medical and mental health problems (79). This parallels trends seen in general medicine which 
are seeking to use single care managers to address multiple conditions in patients with multi-
morbidities (12). These programs may ultimately be more flexible for sites to implement than 
the single-condition disease management programs that have historically dominated both the 
literature and much of the disease-management industry (10). Given high levels of comorbid-
ity in Medicaid clients, these models may be particularly promising to disseminate for patients 
treated in that insurance system.
These clinical approaches to improving quality can be supported through a variety of organiza-
tional/structural relationships that can be categorized into three broad approaches: fully integrat-
ed care provided by a single organization; a partnership model in which care is shared across two 
different organizations; and a facilitated referral approach in which a site helps clients coordinate 
care occurring at multiple different clinics or sites. In contrast to the robust evidence base for 
clinical collaborative care models, there is little research evidence comparing the effectiveness 
of different organizational approaches to supporting care coordination. However, each might be 
expected to pose differential benefits in terms of delivering collaborative care.
14 | RESEARCH SYNTHESIS REPORT NO. 21 | THE ROBERT WOOD JOHNSON FOUNDATION | Mental disorders and medical comorbidity
Findings
In fully integrated medical, mental health, and substance use (MH/SU) health 
models, staff within a single organization provide primary and MH/SU health care. 
These models have been used primarily in large, quasi-integrated systems such as staff model 
HMOs and Veterans Affairs (VA), which include physical facilities that provide co-location of 
mental health, substance use and medical services, and an integrated electronic medical record. 
These systems have administrative and fiscal responsibility for both mental and medical care 
of a defined group of patients, providing a rationale and financial mechanism to support these 
relatively complex and labor-intensive models. 
 A partnership model is one in which primary care staff are embedded in a com-
munity MH/SU organization and/or MH/SU staff are embedded in a primary care 
setting. All 16 sites that have completed the National Council for Community Behavioral 
Healthcare’s Integration Primary Care-Behavioral Health Collaborative have been partnerships 
between community health centers and community MH providers (98). Each site has worked 
on clinical (not organizational) integration, focused on either the primary care or MH setting 
or bi-directionally in both settings. A number of features make this an appealing approach to 
integration. These partnerships provide the embedded staff member with a link to the full range 
of expertise at their home agency via supervision, consultation and referrals. On-site clinicians 
can bill under the license of their home organization, overcoming some of the financial obstacles 
that primary care sites face in providing MH services and vice versa. These approaches may be 
particularly appropriate for midsized organizations such as community mental health centers 
and community health centers that have the infrastructure to develop partnerships but lack the 
resources and economies of scale to develop fully integrated practices.
A facilitated referral model is one in which primary care staff are not physically 
present in the MH/SU organization but the MH/SU organization conducts physical 
health screenings, coordinates referrals to primary care, and shares information 
with primary care. Alternatively, MH/SU staff is not physically present in primary care but  
the primary care provider conducts MH/SU screenings and coordinates referrals to MH/SU  
specialty settings. Typically a care manager, a key element of the collaborative approaches  
described previously, ensures that patients can obtain access to, and follow-up with, care  
outside the organization. Randomized clinical trials have shown that these models, with care  
managers in place ensuring follow-up and transfer of information across the organizations, can 
improve quality and outcomes of depression in primary care and also primary medical care among 
patients with serious mental illnesses (44, 137). Given the low cost and relative flexibility of these 
approaches, they can be useful transitional approaches for smaller sites considering integration. 
None of these organizational approaches guarantees or precludes the delivery of the evidence-
based approaches outlined above. However, these elements are generally easier to support in 
more structured organizational models than in loosely structured referral relationships. A 2006 
Institute of Medicine Report recommended that sites should “transition along a continuum of 
evidence-based coordination models…that best meet the needs of their patient populations, and 
that ensure accountability.” (74) 
Several projects are currently working on taking established collaborative care 
models to scale at a statewide level. These initiatives may provide models for organiza-
tional and financial approaches to improving care at the primary care/mental health interface. 
More than 90 clinics have participated in an initiative known as DIAMOND (Depression Im-
provement Across Minnesota, Offering a New Direction), which uses the IMPACT model of col-
laborative care delivery. Of 151 patients enrolled for at least six months who had been contacted, 
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42 percent were in remission from depression, and an additional 12 percent have seen at  
least a 50 percent improvement in their depressive symptoms (76). To finance this model,  
the DIAMOND project is applying the concept of a case rate payment for depression care.  
Minnesota health plans are paying a monthly per person case rate to participating clinics for a 
bundle of services, including a care manager and consulting psychiatrist, under a single billing 
code. Because the payments are being made from the health care side of the system, there is an  
opportunity for any cost savings to accrue to the health plans paying for the program. 
In the Community Care of North Carolina (CCNC) project, Medicaid enrollees receive health 
care and care management through local networks made up of physicians, hospitals, social  
service agencies and county health departments. Preliminary evidence suggests that these  
programs may help improve quality of care for chronic medical illnesses and save costs (140). 
The CCNC project is a primary care case management model that could serve as a prototype  
for accountable care organizations, providing care management, measurement and quality infra-
structure needed by small practices. In the last several years four CCNC networks have worked 
with state and regional mental health authorities to pilot a model for integrating mental health 
and primary care (155). 
Conclusion
At its core, the problem of comorbidity is one of a mismatch between a clinical reality in which 
medical conditions and mental health conditions are overlapping and interrelated, and a health 
care system in which the providers, clinics and treatments are separated. Evidence-based treat-
ment models for improving quality in this population are often not implemented because of 
barriers erected by the fragmented system. New organizational and financial models, however, 
are being developed to help facilitate the delivery of these services.
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The Patient Protection and Affordable Care Act, signed into law in March 2010, will be a major 
focus for health and mental health policy-makers in the coming years. Given the elevated burden 
and poor quality of care faced by persons with comorbid mental and medical conditions, this 
population merits particular attention as this new legislation is implemented. A number of 
features of health reform, including expanded insurance, support of information technology, 
new organizational and financial models of care, workforce expansion, and resources for preven-
tion hold the opportunity to better disseminate the use of evidence-based approaches to treating 
comorbid conditions in routine care settings.
Expanding insurance. Given high rates of uninsurance and underinsurance among persons 
with mental disorders, expansion of insurance under health reform has the potential to benefit 
persons with comorbid conditions (41). In the context of the recent passage of mental health  
parity legislation, this expanded insurance will include coverage for mental health services that is 
on a par with services for other medical conditions. 
The Medicaid system is already the most important insurer for persons with serious mental ill-
nesses, and its importance will grow under health reform. Donahue and colleagues estimate that 
the proportion of persons with serious mental illness (defined as depression or severe distress) 
treated under Medicaid is likely to nearly double (from 12.8 percent to 24.5 percent) under this 
expansion (35). Given that the health status of new Medicaid enrollees is expected to be similar 
to current beneficiaries, the cost per person will probably not change much, but overall costs to 
the Medicaid system from these enrollees will increase (71).
Many services needed by individuals with mental disorders, particularly those with more serious 
and persistent conditions, do not have a direct equivalent on the physical health side, meaning 
that some individuals insured under these new insurance expansions may still face gaps in  
services. Defining an essential mental health benefits package that includes these services could 
help ensure that expansion of health coverage under health reform translates into improved  
access to services.
Supporting improved communication. Lack of communication between the mental health 
and medical systems has been an important factor underlying poor quality of care for persons 
with comorbid conditions (74). Health Information Exchanges (HIEs) are now being formed 
to develop electronic networks containing data elements essential to care coordination that can 
be accessed by diverse participating health care organizations in a defined geographic region. 
Strategies will need to be developed to allow MH/SU systems to be included in these exchanges, 
while preserving appropriate privacy of sensitive data. The Substance Abuse and Mental Health 
Services Administration recently issued a report concluding that laws protecting confidentiality 
of drug and alcohol abuse information permit inclusion of patients with substance use disorders 
in these networks so long as they provide appropriate consent (100).
Including mental health in medical homes. The Patient Protection and Affordable Care 
Act includes provisions for demonstration projects for patient-centered health homes within 
Medicare and Medicaid. In primary care settings, these patient-centered health homes will need 
to have the capacity to either provide mental health care directly or coordinate with mental 
health providers. Accrediting agencies such as NCQA should be supported in efforts to include 
language about care coordination between medical and mental health services in their certifica-
tion process. For persons with serious and persistent mental conditions, these policies could 
also support the development of specialty care medical homes that provide primary care services 
through community mental health providers. 
Policy Implications
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Developing new financing models. The Patient Protection and Affordable Care Act  
has provisions for developing and testing new models such as Accountable Care Organizations 
(ACOs), collectives of providers that receive bonuses for meeting quality or cost savings  
standards. Membership in ACOs could provide the opportunity for mental health/substance  
use treatment providers to integrate vertically with other components of the health care system,  
and contribute to achieving cost and quality targets. They could provide more flexible funding 
structures to support functions, such as care management, that would be important for improv-
ing care for persons with comorbid conditions. 
Building a trained workforce. There is currently a shortage of providers trained to deliver  
evidence-based services for comorbid conditions; this shortage could become even more 
pronounced with the expansion of the population using health services under health reform 
legislation. The Patient Protection and Affordable Care Act calls for the development of training 
programs that focus on interdisciplinary mental and behavioral health, primary care models such 
as medical homes and team management of chronic disease, and the integration of physical and 
mental health. Workforce development should focus on training and competencies for primary 
care physicians in provision of care for common mental health disorders, mental health clinicians 
in screening and treatment of common medical conditions, and training for each type of provider 
in developing skills for working as consultants in the other setting (104). 
Prioritizing prevention. While improving care for comorbid conditions is critical, it will  
ultimately be essential to work upstream to prevent or delay their onset. Primary prevention 
efforts will be needed to address common risk factors for comorbid conditions, such as adverse 
health behaviors and substance use, in their social and environmental contexts. Secondary pre-
vention should include screening for common mental disorders in primary care settings and for 
common medical health conditions in specialty medical settings. 
Policy Implications
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In conducting this review, several gaps in the literature on mental health and medical  
comorbidity became evident. First, most of the existing literature on comorbidity examines 
the impact of particular comorbid conditions on an index medical or mental illness (e.g.,  
diabetes and depression). While there is value in these specific, clinically-focused approaches 
to understanding comorbidity, patients with comorbid conditions share many common  
features that make them valuable to examine as a distinct population of interest. They are, in 
many ways, analogous to racial and ethnic disparities groups who are monitored separately 
and often require tailored quality improvement programs. Second, nearly all of the current 
evidence for this population focuses on clinical models rather than organizational or systems 
level approaches to implementing those models. Comparative effectiveness trials will be needed 
to compare organizational approaches to delivering and sustaining these evidence-based  
approaches to improving care for persons with comorbid conditions. Finally, health reform 
will include a broad range of changes in insurance coverage and care delivery that could have 
a disproportionate impact on persons with comorbid medical and mental conditions. Tracking 
the impact of this legislation on costs, burden and outcomes of care for this population could 
provide important information to inform future iterations of health legislation. 
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